Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
A polyribosome (polysome or ergosome) is a supramolecular assembly consisting of a single mRNA molecule with multiple ribosomes attached to it, each actively engaged in translating the mRNA into polypeptide chains[1][3][8]. This arrangement increases translational efficiency and allows for the rapid production of numerous protein molecules from a single transcript[1][3][7]. Polysomes can take various shapes—linear, helical, or circular—depending on the organism and context, and their dynamic formation is crucial for regulating gene expression at the translational level[1][8]. Polysome formation reflects the cell's translational activity and is important for cell growth, development, and response to environmental stimuli[2][6]. While not a direct therapeutic target, alterations in polysome structure or function can be indicative of changes in cellular physiology or disease states[2]. In summary: "Polysome formation" does not denote a canonical molecular target but rather a fundamental process of protein synthesis by which multiple ribosomes translate a single mRNA molecule in parallel[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Polyribosome.